NCT02457858View on ClinicalTrials.gov

Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Type 1 Diabetes
Interventions
DRUG

Islet isolation using BMX-010

BMX-010 will be used as a supplement in islet isolation process.

Trial Locations (1)

T6G 2C8

University of Alberta, Edmonton

Sponsors
All Listed Sponsors
collaborator

BioMimetix Pharmaceutical, Inc.

INDUSTRY

lead

University of Alberta

OTHER